Results 111 to 120 of about 476 (138)

Unveiling the anticancer effects of SGLT-2i: mechanisms and therapeutic potential. [PDF]

Front Pharmacol
Sun M, Sun J, Sun W, Li X, Wang Z, Sun L, Wang Y.   +6 more
europepmc   +1 more source

Efficacy and Safety of Tofogliflozin and Ipragliflozin for Patients with Type-2 Diabetes: A Randomized Crossover Study by Flash Glucose Monitoring. [PDF]

Diabetes Ther, 2020
Kawaguchi Y, Sawa J, Kumeda Y.
europepmc   +1 more source

Serum uric acid reduction through SGLT2 inhibitors: evidence from a systematic review and meta-analysis. [PDF]

Front Pharmacol
Yang S, Hu Q, Liu K, Xiao B, Zhang B, Su N.   +5 more
europepmc   +1 more source

Sodium glucose cotransporter 2 inhibitor suppresses renal injury in rats with renal congestion. [PDF]

Hypertens Res
Endo A, Hirose T, Sato S, Ito H, Takahashi C, Ishikawa R, Kamada A, Oba-Yabana I, Kimura T, Takahashi K, Mori T.   +10 more
europepmc   +1 more source

Corrigendum: Novel approach to studying marine fauna: using long-life remote underwater video cameras to assess occurrence and behaviour of threatened and data-deficient elasmobranch species in southern Mozambique

Frontiers in Marine Science
Jule Buschmann, Jule Buschmann, Kim G. Roques, Jaime S. Davies, Jaime S. Davies, Awantha Dissanayake, Jennifer A. Keeping, Jennifer A. Keeping   +7 more
doaj   +1 more source

Tofogliflozin Delays Portal Hypertension and Hepatic Fibrosis by Inhibiting Sinusoidal Capillarization in Cirrhotic Rats. [PDF]

Cells
Asada S, Kaji K, Nishimura N, Koizumi A, Matsuda T, Tanaka M, Yorioka N, Sato S, Kitagawa K, Namisaki T, Akahane T, Yoshiji H.   +11 more
europepmc   +1 more source

The Role of Sodium Glucose Co-Transporter 2 Inhibitors in Atrial Fibrillation: A Comprehensive Review. [PDF]

J Clin Med
Stachteas P, Nasoufidou A, Karagiannidis E, Patoulias D, Karakasis P, Alexiou S, Samaras A, Zormpas G, Stavropoulos G, Tsalikakis D, Kassimis G, Papadopoulos C, Fragakis N.   +12 more
europepmc   +1 more source

Long-term safety and efficacy of tofogliflozin as add-on to insulin in patients with type 2 diabetes: Results from a 52-week, multicentre, randomized, double-blind, open-label extension, Phase 4 study in Japan (J-STEP/INS). [PDF]

Diabetes Obes Metab, 2018
Terauchi Y, Tamura M, Senda M, Gunji R, Kaku K.   +4 more
europepmc   +1 more source

Influence of long term administration of tofogliflozin on chronic inflammation of visceral adipose tissue in mice with obesity induced by a high-fat diet. [PDF]

PLoS One, 2019
Shirakawa K, Yano W, Inoue K, Katsumata Y, Endo J, Sano M.   +5 more
europepmc   +1 more source

Effects of sodium-glucose cotransporter 2 inhibitor, tofogliflozin, on the indices of renal tubular function in patients with type 2 diabetes. [PDF]

Endocrinol Diabetes Metab, 2018
Nunoi K, Sato Y, Kaku K, Yoshida A, Suganami H.   +4 more
europepmc   +1 more source